Onconano Medicine, Inc.

ACTIVE

181 Grand Ave Ste 225, Southlake, Texas, United Stateswww.onconano.comHolding11–50 employeesEstablished: 2014-12-29

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2014

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

75.0%

Phase 1

25.0%

Trial Status Distribution

Completed

75.0%

Recruiting

25.0%

Clinical Trials

Trials sponsored by this organization (4)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Phase 1

Recruiting

interventional

Oct 2023168 participants

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies

Phase 2

Completed

interventional

Apr 202224 participants

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

Phase 2

Completed

interventional

Nov 202151 participants

A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Phase 2

Completed

interventional

Aug 201930 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations